Detalles de la búsqueda
1.
Inetetamab in combination with rapamycin and chemotherapy for trastuzumab-treated metastatic human epidermal growth factor receptor 2-positive breast cancer with abnormal activation of PI3K/Akt/mTOR pathway.
Cancer Rep (Hoboken)
; 6(9): e1864, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37501598
2.
A treatment planning comparison between proton beam therapy and intensity-modulated x-ray therapy for recurrent nasopharyngeal carcinoma.
J Xray Sci Technol
; 18(4): 443-50, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21045280
3.
[Dose distributions of proton beam therapy for hepatocellular carcinoma: a comparative study of treatment planning with 3D-conformal radiation therapy or intensity-modulated radiation therapy].
Zhonghua Yi Xue Za Zhi
; 89(45): 3201-6, 2009 Dec 08.
Artículo
en Zh
| MEDLINE | ID: mdl-20193534
4.
Apatinib Mesylate in the treatment of advanced progressed lung adenocarcinoma patients with EGFR-TKI resistance -A Multicenter Randomized Trial.
Sci Rep
; 9(1): 14013, 2019 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31570733
5.
Comparative assessment of efficacy and safety of different treatment for de novo overactive bladder children: A systematic review and network meta-analysis.
Asian J Urol
; 6(4): 330-338, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31768318
Resultados
1 -
5
de 5
1
Próxima >
>>